首页 > 最新文献

Problemy tuberkuleza i boleznei legkikh最新文献

英文 中文
[Generalized tuberculous infection in infants]. [婴儿全身性结核感染]。
F A Batyrov, O K Kiselevich, I V Shirshov

Tuberculosis in infants is characterized by the evolving generalization of the process. By analyzing the 10-year records made in infants by tuberculosis hospital seven, the authors have revealed that generalized forms of tuberculosis develop in every 10 tuberculosis infants at an early age. When this form of tuberculosis develops at an early age, every ten infants die. It is necessary to treat on an individual basis, intensively, and long. The use of larger dose antituberculous drugs is justifiable.

婴儿结核病的特点是该过程的不断发展。通过分析7家结核病医院的10年婴儿记录,作者揭示了每10名结核病婴儿在早期就会出现普遍形式的结核病。当这种形式的结核病在幼年发展时,每十个婴儿就会死亡。有必要在个人基础上进行集中和长期的治疗。使用大剂量的抗结核药物是合理的。
{"title":"[Generalized tuberculous infection in infants].","authors":"F A Batyrov,&nbsp;O K Kiselevich,&nbsp;I V Shirshov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Tuberculosis in infants is characterized by the evolving generalization of the process. By analyzing the 10-year records made in infants by tuberculosis hospital seven, the authors have revealed that generalized forms of tuberculosis develop in every 10 tuberculosis infants at an early age. When this form of tuberculosis develops at an early age, every ten infants die. It is necessary to treat on an individual basis, intensively, and long. The use of larger dose antituberculous drugs is justifiable.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 1","pages":"45-8"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28015678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The fibrinolytic system in the hypercoagulation syndrome in patients with pulmonary tuberculosis]. [肺结核患者高凝综合征的纤溶系统]。
G O Kaminskaia, E V Martynova, B A Serebrianaia, O G Komissarova

One hundred and twenty-four patients with different forms of active pulmonary tuberculosis were examined. The fibrinolytic system was assessed from the time of plasma fibrin clot lysis, plasminogen (PG) concentrations, and alpha2-antiplasmin (alpha2-AP) activity. The findings were compared with the recordings of a coagulogram, the concentration ofintravascular coagulation (IVC) markers--soluble fibrinmonomer complexes (SFMC) and D-dimers (DD), as well as with systemic inflammation indices (C-reactive protein and haptoglobin). The patients with pulmonary tuberculosis were found to have a hypercoagulation shift in the hemostatic system, which was accompanied by IVC events and quantitatively associated with the degree of systemic inflammation. This was followed by the moderately elevated PG concentrations in a third of patients and enhanced alpha2-AP activity in two thirds. The prevailing alpha2-AP rise resulted in delayed forming fibrin lysis. When influenced by a number of competitive factors, the values of PG and alpha2-AP directly correlated only with fibrinogen levels (directly). The concentration of DD directly correlated with the markers of systemic inflammation and SFMC, showed no correlations with the indices of the fibrinolytic and hemostatic systems. No correlations between PG, alpha2-AP, and DD suggests that in addition to secretion of corresponding factors, processes of their uptake play a large role in the formation of the functional status of the fibrinolytic system.

对124例不同形式的活动性肺结核患者进行了检查。从血浆纤维蛋白凝块溶解时间、纤溶酶原(PG)浓度和α 2-抗纤溶酶(α 2- ap)活性来评估纤溶系统。将这些结果与凝血图记录、血管内凝血(IVC)标志物——可溶性纤维蛋白单体复合物(SFMC)和d -二聚体(DD)的浓度以及全身炎症指标(c反应蛋白和触珠蛋白)进行比较。发现肺结核患者在止血系统中存在高凝移位,并伴有IVC事件,并与全身炎症程度定量相关。随后,三分之一的患者PG浓度中度升高,三分之二的患者α 2- ap活性增强。普遍的α 2- ap升高导致延迟形成纤维蛋白裂解。当受到多种竞争因素的影响时,PG和alpha2-AP的值仅与纤维蛋白原水平直接相关(直接)。DD浓度与全身炎症和SFMC指标直接相关,与纤溶和止血系统指标无相关性。PG、alpha2-AP、DD三者之间均无相关性,提示除了相应因子的分泌外,它们的摄取过程在纤溶系统功能状态的形成中起着重要作用。
{"title":"[The fibrinolytic system in the hypercoagulation syndrome in patients with pulmonary tuberculosis].","authors":"G O Kaminskaia,&nbsp;E V Martynova,&nbsp;B A Serebrianaia,&nbsp;O G Komissarova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>One hundred and twenty-four patients with different forms of active pulmonary tuberculosis were examined. The fibrinolytic system was assessed from the time of plasma fibrin clot lysis, plasminogen (PG) concentrations, and alpha2-antiplasmin (alpha2-AP) activity. The findings were compared with the recordings of a coagulogram, the concentration ofintravascular coagulation (IVC) markers--soluble fibrinmonomer complexes (SFMC) and D-dimers (DD), as well as with systemic inflammation indices (C-reactive protein and haptoglobin). The patients with pulmonary tuberculosis were found to have a hypercoagulation shift in the hemostatic system, which was accompanied by IVC events and quantitatively associated with the degree of systemic inflammation. This was followed by the moderately elevated PG concentrations in a third of patients and enhanced alpha2-AP activity in two thirds. The prevailing alpha2-AP rise resulted in delayed forming fibrin lysis. When influenced by a number of competitive factors, the values of PG and alpha2-AP directly correlated only with fibrinogen levels (directly). The concentration of DD directly correlated with the markers of systemic inflammation and SFMC, showed no correlations with the indices of the fibrinolytic and hemostatic systems. No correlations between PG, alpha2-AP, and DD suggests that in addition to secretion of corresponding factors, processes of their uptake play a large role in the formation of the functional status of the fibrinolytic system.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 3","pages":"51-4"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28185958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tuberculosis morbidity in the Republic of Kazakhstan under new economic conditions]. [新经济条件下哈萨克斯坦共和国肺结核发病率]。
L G Sataeva

The impact of economic reformation on the incidence of tuberculosis has been studied in the Republic of Kazakhstan under new economic conditions. The highest tuberculosis morbidity rate regions have identified. The level of income is given by the country's regions and the lowest tuberculosis morbidity rate is shown in the best financial regions. The author shows that despite the fact that in the past years the socioeconomic indices have improved in the Republic of Kazakhstan as a whole, but in not all population groups they are increasing equally. The incomes of pensioners, unemployed, and workers of the budgetary sector remain low, causing a significant increase in the morbidity of tuberculosis in these social groups. The author notes that reducing the incidence of tuberculosis primarily requires improvement of the mechanisms of social protection (including the increase of the efficiency of provision of the most socially vulnerable strata with drugs).

在新的经济条件下,哈萨克斯坦共和国研究了经济改革对结核病发病率的影响。结核病发病率最高的地区已确定。收入水平按国家各地区分列,最低的结核病发病率显示在财政状况最好的地区。作者指出,尽管过去几年哈萨克斯坦共和国的社会经济指数作为一个整体有所改善,但并非所有人口群体的社会经济指数都在平等地增长。养老金领取者、失业者和预算部门工人的收入仍然很低,导致这些社会群体的结核病发病率显著增加。作者指出,减少结核病发病率主要需要改善社会保护机制(包括提高向社会最脆弱阶层提供药物的效率)。
{"title":"[Tuberculosis morbidity in the Republic of Kazakhstan under new economic conditions].","authors":"L G Sataeva","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The impact of economic reformation on the incidence of tuberculosis has been studied in the Republic of Kazakhstan under new economic conditions. The highest tuberculosis morbidity rate regions have identified. The level of income is given by the country's regions and the lowest tuberculosis morbidity rate is shown in the best financial regions. The author shows that despite the fact that in the past years the socioeconomic indices have improved in the Republic of Kazakhstan as a whole, but in not all population groups they are increasing equally. The incomes of pensioners, unemployed, and workers of the budgetary sector remain low, causing a significant increase in the morbidity of tuberculosis in these social groups. The author notes that reducing the incidence of tuberculosis primarily requires improvement of the mechanisms of social protection (including the increase of the efficiency of provision of the most socially vulnerable strata with drugs).</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 2","pages":"29-32"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28200549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessment of the training of phthisiatricians in the regions of Russia]. [对俄罗斯各地区肺结核医生培训的评估]。
E M Bogorodskaia, S E Borisov, T N Ivanushkina, N I Klevno
{"title":"[Assessment of the training of phthisiatricians in the regions of Russia].","authors":"E M Bogorodskaia,&nbsp;S E Borisov,&nbsp;T N Ivanushkina,&nbsp;N I Klevno","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 5","pages":"60-3"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28277001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical trials of the new skin test Diaskintest for the diagnosis of tuberculosis]. 【新型皮肤试验Diaskintest诊断肺结核的临床试验】。
V I Kiselev, P M Baranovskiĭ, I V Rudykh, A M Shuster, V A Mart'ianov, B L Mednikov, A V Demin, A N Aleksandrov, A Iu Mushkin, D T Levi, L V Slogotskaia, E S Ovsiankina, N V Medunitsin, V I Litvinov, M I Perel'man, M A Pal'tsev

A new reagent for a skin test given the name Diaskintest has been designed for the screening diagnosis of tuberculosis and preclinical and clinical trials conducted. Preclinical trials were carried out on 315 laboratory animals (guinea-pigs, albino mice). The reagent Diaskintest was ascertained to be nontoxic, to have no sensitizing properties, to be safe and specific, and to induce no positive reactions in BCG-vaccinated animals and healthy guinea-pigs. Its specific activity was comparable with that of the national reference--purified tuberculin PPD-L-2. With progression of tuberculous lesions, the guinea-pigs showed higher responses to Diaskintest dilution and the BCG-vaccinated animals lacked responses to Diaskintest with increased delayed type hypersensitivity. The clinical trial was permitted by the Federal Service for Surveillance in Health Care and Social Development of the Russian Federation. Clinical trials were conducted in 150 persons. The safety, specificity, sensitivity of Diaskintest were first examined in the clinical studies and its action was compared with the results of tuberculin skin test (Mantoux test) with 2 TE of PPD L-2. Diaskintest was ascertained to be highly sensitive when given in a dose of 0.2 microg in 0.1 ml. In patients with active tuberculosis and new cases of Mycobacterium tuberculosis infection, the agent induced a positive skin reaction (a papule of more than 10 mm) in 98-100% of cases (p < 0.05). The agent caused no reaction associated with BCG vaccination. The specificity of the test was 93-100% with 95% significance. The rate of overexuberant reactions (vesicular necrotic changes, lymphangitis, and lymphadenitis) was 4-14% with 95% significance. Tuberculosis patients with significant immunopathological disorders might have no skin sensitivity to Diaskintest, as to PPD L-2 (a negative test). The findings substantiate the use of Diaskintest for mass epidemiological surveys for the differential diagnosis of tuberculosis and BCG vaccination-associated complications. The agent may be also used to evaluate the activity of the process in patients with tuberculosis and the efficiency of treatment in combination with other methods and to make a differential diagnosis of tuberculosis.

设计了一种名为Diaskintest的皮肤试验新试剂,用于结核病的筛查诊断和临床前和临床试验。对315只实验动物(豚鼠、白化小鼠)进行了临床前试验。结果表明,该试剂无毒、无致敏性、安全、特异性强,对接种bcg的动物和健康豚鼠均无阳性反应。其比活性与国家标准纯化结核菌素PPD-L-2相当。随着结核病变的进展,豚鼠对Diaskintest稀释剂表现出更高的反应,而接种bcg的动物对Diaskintest缺乏反应,延迟型超敏反应增加。临床试验得到了俄罗斯联邦保健和社会发展联邦监督局的许可。临床试验在150人中进行。首先在临床研究中考察了Diaskintest的安全性、特异性和敏感性,并将其作用与结核菌素皮肤试验(Mantoux试验)与PPD L-2 2 TE的结果进行了比较。当给药剂量为0.2 mg / 0.1 ml时,Diaskintest被确定为高度敏感。在活动性肺结核患者和新发结核分枝杆菌感染病例中,98-100%的病例引起皮肤阳性反应(大于10 mm的丘疹)(p < 0.05)。该制剂未引起与卡介苗接种相关的反应。特异性为93 ~ 100%,显著性为95%。过度反应(水泡性坏死改变、淋巴管炎和淋巴结炎)的发生率为4-14%,具有95%的显著性。具有明显免疫病理障碍的结核病患者可能对Diaskintest和PPD L-2(阴性试验)没有皮肤敏感性。研究结果证实了使用Diaskintest进行大规模流行病学调查以鉴别诊断结核病和卡介苗接种相关并发症。该制剂还可用于评价该工艺在结核病患者中的活性和与其他方法联合治疗的效率,并对结核病进行鉴别诊断。
{"title":"[Clinical trials of the new skin test Diaskintest for the diagnosis of tuberculosis].","authors":"V I Kiselev,&nbsp;P M Baranovskiĭ,&nbsp;I V Rudykh,&nbsp;A M Shuster,&nbsp;V A Mart'ianov,&nbsp;B L Mednikov,&nbsp;A V Demin,&nbsp;A N Aleksandrov,&nbsp;A Iu Mushkin,&nbsp;D T Levi,&nbsp;L V Slogotskaia,&nbsp;E S Ovsiankina,&nbsp;N V Medunitsin,&nbsp;V I Litvinov,&nbsp;M I Perel'man,&nbsp;M A Pal'tsev","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A new reagent for a skin test given the name Diaskintest has been designed for the screening diagnosis of tuberculosis and preclinical and clinical trials conducted. Preclinical trials were carried out on 315 laboratory animals (guinea-pigs, albino mice). The reagent Diaskintest was ascertained to be nontoxic, to have no sensitizing properties, to be safe and specific, and to induce no positive reactions in BCG-vaccinated animals and healthy guinea-pigs. Its specific activity was comparable with that of the national reference--purified tuberculin PPD-L-2. With progression of tuberculous lesions, the guinea-pigs showed higher responses to Diaskintest dilution and the BCG-vaccinated animals lacked responses to Diaskintest with increased delayed type hypersensitivity. The clinical trial was permitted by the Federal Service for Surveillance in Health Care and Social Development of the Russian Federation. Clinical trials were conducted in 150 persons. The safety, specificity, sensitivity of Diaskintest were first examined in the clinical studies and its action was compared with the results of tuberculin skin test (Mantoux test) with 2 TE of PPD L-2. Diaskintest was ascertained to be highly sensitive when given in a dose of 0.2 microg in 0.1 ml. In patients with active tuberculosis and new cases of Mycobacterium tuberculosis infection, the agent induced a positive skin reaction (a papule of more than 10 mm) in 98-100% of cases (p < 0.05). The agent caused no reaction associated with BCG vaccination. The specificity of the test was 93-100% with 95% significance. The rate of overexuberant reactions (vesicular necrotic changes, lymphangitis, and lymphadenitis) was 4-14% with 95% significance. Tuberculosis patients with significant immunopathological disorders might have no skin sensitivity to Diaskintest, as to PPD L-2 (a negative test). The findings substantiate the use of Diaskintest for mass epidemiological surveys for the differential diagnosis of tuberculosis and BCG vaccination-associated complications. The agent may be also used to evaluate the activity of the process in patients with tuberculosis and the efficiency of treatment in combination with other methods and to make a differential diagnosis of tuberculosis.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 2","pages":"11-6"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28121691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs]. 结核分枝杆菌耐药肺结核的外科治疗。
O N Ots, T V Agkatsev, M I Perel'man

The results of surgical treatment were analyzed in 481 patients who had been preoperatively found to have drug resistance. Patients with fibrocavernous, cirrhotic tuberculosis, chronic pleural empyema, and cavernous pneumonia constituted the vast majority (83.2%). Chemotherapy was performed by individual schemes, by taking into account MBT susceptibility. Glutoxim and pentaglobin were used as pathogenetic therapy for immunity correction. Resection-type operations [n = 368 (68.9%)], thorocoplastic interventions [n = 78 (14.6%)], thoracostomy or cavernostomy [n = 35 (6.5%)], pleurectomy [n = 26 (4.9%)], operation on the stump of the main bronchus [n = 15 (2.8%)], and mediastinal lymphadenectomy [n = 12 (2.2%)] were predominant. Postoperative complications occurred in 15.5% of cases; mortality was 1.7%. The mycobacterium resistance to drugs verified by laboratory studies exerted no evident impact on the number and pattern of postoperative complications. The results of treatment depended on the extent and presence of complications of a tuberculous process, comorbidity, suppressed immunity, and the scope of a surgical intervention.

对术前发现耐药的481例患者的手术治疗结果进行分析。纤维海绵状、肝硬化结核、慢性胸膜脓肿和海绵状肺炎患者占绝大多数(83.2%)。化疗采用个别方案,考虑到MBT的易感性。采用糖毒素和五血红蛋白作为致病药物进行免疫纠正。以切除型手术[n = 368(68.9%)]、胸廓成形术[n = 78(14.6%)]、开胸或海绵体造口术[n = 35(6.5%)]、胸膜切除术[n = 26(4.9%)]、主支气管残端手术[n = 15(2.8%)]、纵隔淋巴结切除术[n = 12(2.2%)]为主。术后并发症发生率为15.5%;死亡率为1.7%。实验室证实的分枝杆菌耐药对术后并发症的数量和模式无明显影响。治疗的结果取决于结核过程并发症的程度和存在、合并症、抑制免疫和手术干预的范围。
{"title":"[Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs].","authors":"O N Ots,&nbsp;T V Agkatsev,&nbsp;M I Perel'man","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The results of surgical treatment were analyzed in 481 patients who had been preoperatively found to have drug resistance. Patients with fibrocavernous, cirrhotic tuberculosis, chronic pleural empyema, and cavernous pneumonia constituted the vast majority (83.2%). Chemotherapy was performed by individual schemes, by taking into account MBT susceptibility. Glutoxim and pentaglobin were used as pathogenetic therapy for immunity correction. Resection-type operations [n = 368 (68.9%)], thorocoplastic interventions [n = 78 (14.6%)], thoracostomy or cavernostomy [n = 35 (6.5%)], pleurectomy [n = 26 (4.9%)], operation on the stump of the main bronchus [n = 15 (2.8%)], and mediastinal lymphadenectomy [n = 12 (2.2%)] were predominant. Postoperative complications occurred in 15.5% of cases; mortality was 1.7%. The mycobacterium resistance to drugs verified by laboratory studies exerted no evident impact on the number and pattern of postoperative complications. The results of treatment depended on the extent and presence of complications of a tuberculous process, comorbidity, suppressed immunity, and the scope of a surgical intervention.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 2","pages":"42-9"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28122114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Osteal scintigraphy in the evaluation of the course of reparative processes after surgical treatment for tuberculous and nonspecific arthritis, by using constrained bone grafting]. [骨显像在评估结核性和非特异性关节炎手术治疗后的修复过程中,通过约束骨移植]。
I B Savin, N A Sovetova, M S Serdobintsev, G D Nakonechnyĭ

Osteal scintigraphy was used to study the course of reparative processes after surgical treatment in 106 patients with large joint lesions, including 76 patients with tuberculous arthritis and their sequels and 30 with nonspecific and dystrophicones before and 2-3 weeks after operations (those with and without articular tissue revascularization (n = 43 and n = 63); mobilizing (n = 64) and stabilizing (n = 42) operations), of them 22 being performed in late periods (1-3 years (n = 16)). It was established that after mobilizing operations with revascularization, the early postoperative period was marked by a significant increase in radionuclide accumulation (by 1.52 times) and after those without revascularization, there was a less significant rise (by 1.34 times); following stabilizing operations with revascularization, hyperfixation was similar before and after surgery whereas following those without revascularization it significantly reduced (by 1.53% in 70% of patients). The late postoperative period was characterized by reduced hyperfixation, which was more evident after mobilizing operations with revascularization. Osteal scintigraphy quantifies the course of reparative processes and determines the efficiency of different operations.

应用骨显像技术研究106例大关节病变患者手术后的修复过程,其中结核性关节炎及其后遗症患者76例,非特异性和肌营养不良患者30例,术前和术后2-3周(有和没有关节组织血运重建术(n = 43和n = 63);动员手术(n = 64)和稳定手术(n = 42),其中22例在晚期(1-3年)进行(n = 16)。结果表明,在有血运重建的动员手术后,术后早期放射性核素积累明显增加(增加1.52倍),未有血运重建的动员手术后,放射性核素积累增加不明显(增加1.34倍);在稳定手术合并血运重建术后,手术前后的过度固定相似,而在没有血运重建术的患者中,过度固定明显减少(70%的患者减少1.53%)。术后后期的特点是过度固定减少,在活动手术伴血运重建后更为明显。骨闪烁成像量化了修复过程的过程,并确定了不同操作的效率。
{"title":"[Osteal scintigraphy in the evaluation of the course of reparative processes after surgical treatment for tuberculous and nonspecific arthritis, by using constrained bone grafting].","authors":"I B Savin,&nbsp;N A Sovetova,&nbsp;M S Serdobintsev,&nbsp;G D Nakonechnyĭ","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Osteal scintigraphy was used to study the course of reparative processes after surgical treatment in 106 patients with large joint lesions, including 76 patients with tuberculous arthritis and their sequels and 30 with nonspecific and dystrophicones before and 2-3 weeks after operations (those with and without articular tissue revascularization (n = 43 and n = 63); mobilizing (n = 64) and stabilizing (n = 42) operations), of them 22 being performed in late periods (1-3 years (n = 16)). It was established that after mobilizing operations with revascularization, the early postoperative period was marked by a significant increase in radionuclide accumulation (by 1.52 times) and after those without revascularization, there was a less significant rise (by 1.34 times); following stabilizing operations with revascularization, hyperfixation was similar before and after surgery whereas following those without revascularization it significantly reduced (by 1.53% in 70% of patients). The late postoperative period was characterized by reduced hyperfixation, which was more evident after mobilizing operations with revascularization. Osteal scintigraphy quantifies the course of reparative processes and determines the efficiency of different operations.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 2","pages":"61-4"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28122118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Roncoleukin in enhancing the efficiency of complex therapy for infiltrative pulmonary tuberculosis in adolescents]. [Roncoleukin在提高青少年浸润性肺结核综合治疗中的疗效]。
N A Barmina, L V Burukhina, A A Shurygin, L I Archakova

Seventy-eight patients, aged 15.69 +/- 0.15 years, who had infiltrative pulmonary tuberculosis, were examined. Roncoleukin was given intravenously in 20 patients of them (Subgroup 1a), in an indirect lymphotropic fashion in 30 patients (Subgroup 1b); 28 adolescents were treated with the conventional treatments (Group 2). A decay phase was recorded in 33 (66%) from Group 1 and in 16 (57.1%) from Group 2. On admission, all 78 (100%) patients had immunological disorders that required immunomodulation. Roncoleukin caused positive clinical and X-ray changes that were more pronounced in Subgroup 1b: bacterial excretion cessation was recorded in 100% of patients in Subgroup 1a (p < 0.05); in 94.4% in Subgroup 1b (p < 0.05), and in 68.7% in Group 2; decay cavities closed in 69.2, 60, and 37.5% in Subgroups 1a and 1b and Group 2. At the same time, the duration of a procedure considerably reduced, which positively affected adolescents' compliance.

本文对78例浸润性肺结核患者进行了检查,年龄15.69±0.15岁。其中20例患者(1a亚组)静脉给予Roncoleukin, 30例患者(1b亚组)以间接淋巴性方式给予Roncoleukin;对照组28例,对照组33例(66%),对照组16例(57.1%)出现龋期。入院时,所有78例(100%)患者均有需要免疫调节的免疫紊乱。龙白细胞素引起的临床和x线阳性变化在1b亚组中更为明显:1a亚组中100%的患者记录了细菌排泄停止(p < 0.05);1b亚组为94.4% (p < 0.05), 2亚组为68.7%;1a、1b亚组和2亚组龋齿闭合率分别为69.2、60、37.5%。同时,程序的持续时间大大缩短,这对青少年的依从性产生了积极影响。
{"title":"[Roncoleukin in enhancing the efficiency of complex therapy for infiltrative pulmonary tuberculosis in adolescents].","authors":"N A Barmina,&nbsp;L V Burukhina,&nbsp;A A Shurygin,&nbsp;L I Archakova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Seventy-eight patients, aged 15.69 +/- 0.15 years, who had infiltrative pulmonary tuberculosis, were examined. Roncoleukin was given intravenously in 20 patients of them (Subgroup 1a), in an indirect lymphotropic fashion in 30 patients (Subgroup 1b); 28 adolescents were treated with the conventional treatments (Group 2). A decay phase was recorded in 33 (66%) from Group 1 and in 16 (57.1%) from Group 2. On admission, all 78 (100%) patients had immunological disorders that required immunomodulation. Roncoleukin caused positive clinical and X-ray changes that were more pronounced in Subgroup 1b: bacterial excretion cessation was recorded in 100% of patients in Subgroup 1a (p < 0.05); in 94.4% in Subgroup 1b (p < 0.05), and in 68.7% in Group 2; decay cavities closed in 69.2, 60, and 37.5% in Subgroups 1a and 1b and Group 2. At the same time, the duration of a procedure considerably reduced, which positively affected adolescents' compliance.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 5","pages":"27-31"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28275893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prediction of the major tuberculosis epidemiological parameters among the children of the Udmurt Republic]. [预测乌德穆尔特共和国儿童结核病的主要流行病学参数]。
Iu P Chugaev, D N Golubev, O V Moiseeva

The tuberculosis epidemiological situation was studied among the children of the Udmurt Republic and the tuberculosis morbidity rates in children, the risk of primary infection, and the infection rates were predicted by the Bayes procedure. To study the impact of chemoprophylaxis on the incidence of tuberculosis in children, the risk of its primary infection, and the infection rates, the authors used the multivariate statistical method--hypotheses theorem (the Bayes formula). The application of the hypotheses theorem has shown that if the cohort of children who had chemoprophylaxis in 2007, they should receive it at the same rate as in 2002, which is 30% greater, the morbidity rates in children should show a 1.1-fold reduction.

研究乌德穆尔特共和国儿童结核病流行病学情况,采用贝叶斯方法预测儿童结核病发病率、原发性感染风险和感染率。为了研究化学预防对儿童结核病发病率、原发性感染风险和感染率的影响,作者使用了多元统计方法——假设定理(贝叶斯公式)。假设定理的应用表明,如果2007年接受化学预防治疗的儿童队列与2002年相同,即比2002年高30%,则儿童发病率应降低1.1倍。
{"title":"[Prediction of the major tuberculosis epidemiological parameters among the children of the Udmurt Republic].","authors":"Iu P Chugaev,&nbsp;D N Golubev,&nbsp;O V Moiseeva","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The tuberculosis epidemiological situation was studied among the children of the Udmurt Republic and the tuberculosis morbidity rates in children, the risk of primary infection, and the infection rates were predicted by the Bayes procedure. To study the impact of chemoprophylaxis on the incidence of tuberculosis in children, the risk of its primary infection, and the infection rates, the authors used the multivariate statistical method--hypotheses theorem (the Bayes formula). The application of the hypotheses theorem has shown that if the cohort of children who had chemoprophylaxis in 2007, they should receive it at the same rate as in 2002, which is 30% greater, the morbidity rates in children should show a 1.1-fold reduction.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 6","pages":"5-7"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40000426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis]. [新发破坏性肺结核患者结核分枝杆菌的原发性耐药]。
I P Zinov'ev, N A Esaulova, V G Novikov, I A Kokovikhina

In 2005-2007, primary drug resistance of Mycobacterium tuberculosis (MBT) was studied in 1318 patients with new-onset destructive pulmonary tuberculosis. This was identified in 31.8, 28.5, and 29.1% in 2005, 2006, and 2007, respectively. During these years, there was an increase in the primary rifampicin resistance of MBT from 28.8% in 2005 to 37.7% in 2007. Primary streptomycin resistance was 100% in 2007. The authors consider the primary resistance of MBT as a priority problem of phthisiology.

2005-2007年对1318例新发破坏性肺结核患者的结核分枝杆菌(MBT)进行了一次耐药性研究。在2005年、2006年和2007年,这一比例分别为31.8%、28.5%和29.1%。在这些年中,MBT的利福平初级耐药性从2005年的28.8%增加到2007年的37.7%。2007年原发性链霉素耐药性为100%。作者认为MBT的原发耐药是生理学的一个优先问题。
{"title":"[Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].","authors":"I P Zinov'ev,&nbsp;N A Esaulova,&nbsp;V G Novikov,&nbsp;I A Kokovikhina","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 2005-2007, primary drug resistance of Mycobacterium tuberculosis (MBT) was studied in 1318 patients with new-onset destructive pulmonary tuberculosis. This was identified in 31.8, 28.5, and 29.1% in 2005, 2006, and 2007, respectively. During these years, there was an increase in the primary rifampicin resistance of MBT from 28.8% in 2005 to 37.7% in 2007. Primary streptomycin resistance was 100% in 2007. The authors consider the primary resistance of MBT as a priority problem of phthisiology.</p>","PeriodicalId":85348,"journal":{"name":"Problemy tuberkuleza i boleznei legkikh","volume":" 4","pages":"37-9"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28232213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Problemy tuberkuleza i boleznei legkikh
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1